Repository

Publications

New platinum derivatives selectively cause double-strand DNA breaks and death in naïve and cisplatin-resistant cholangiocarcinomas

Olaizola I, Odriozola-Gimeno M, Olaizola P, Caballero-Camino FJ, Pastor-Toyos N, Tena-Garitaonandia M, Lapitz A, Val B, Guimaraes AR, Asensio M, Huici-Izagirre M, Rae C, de Sancho D, Lopez X, Rodrigues PM, Herraez E, Briz O, Izquierdo-Sanchez L, Eleta-Lopez A, Bittner AM, Martinez-Amesti A, Miranda T, Ilyas SI, Braconi C, Perugorria MJ, Bujanda L, Rivilla I, Marin JJG, Cossio FP, Banales JM
J Hepatol . 2025 Nov;83(5):1077-1091. doi: 10.1016/j.jhep.2025.04.034
2025 
Result from  

Efficacy and Toxicity of Pemigatinib in Advanced Cholangiocarcinoma Harboring FGFR Fusions or Rearrangements: A Systematic Review and Meta-analysis

Akkus E, Yasar HA, Rimassa L, Lamarca A
Target Oncol . 2025 May;20(3):389-403. doi: 10.1007/s11523-025-01142-8
2025 
Result from  
Funded by  

Liposomal irinotecan for previously treated patients with biliary tract cancer: A pooled analysis of NIFTY and NALIRICC trials

Yoo C, Saborowski A, Hyung J, Wenzel P, Kim I, Wege H, Kim K, Folprecht G, Ryoo B, Schütt P, Cheon J, Götze T, Ryu H, Lee J, Vogel A
J Hepatol . 2025 Oct;83(4):909-916. doi: 10.1016/j.jhep.2025.03.013
2025 

Deciphering the spatial tumor microenvironment in intrahepatic cholangiocarcinoma

Macias RIR, Roessler S, Verstegen MMA
Hepatology. 2026 Jan 1;83(1):8-10. doi: 10.1097/HEP.0000000000001322
2026 
Result from  

Mutational Analysis of Bile Cell-Free DNA in Primary Sclerosing Cholangitis: A Pilot Study

Arechederra M, Bik E, Rojo C, Elurbide J, Elizalde M, Kruk B, Krasnodębski M, Pertkiewicz J, Kozieł S, Grąt M, Raszeja-Wyszomirska J, Rullan M, Alkorta-Aranburu G, Oyón D, Fernández-Barrena M, Candels L, Białek A, Krupa Ł, Schneider K, Urman J, Strnad P, Trautwein C, Milkiewicz P, Krawczyk M, Ávila M, Berasain C
Liver Int . 2025 Apr;45(4):e70049. doi: 10.1111/liv.70049
2025 
Result from  
Join the Action
JOIN